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Elevated levels of irritability are reported to occur in a number of neurological conditions, 
including Huntington’s disease, a genetic neurodegenerative disorder.   
Objectives 
Snaith’s Irritability Scale is used within Huntington’s disease research, but no psychometric 
evaluation of this instrument has previously been undertaken. Therefore, the current study 
aimed to analyze the factor structure of this scale among a Huntington’s disease population. 
Methods 
Exploratory and confirmatory factor analysis were used to examine the structural properties 
of Snaith’s Irritability Scale using responses from 1264 Huntington’s disease gene expansion 
carriers, across 15 European countries, who were engaged in the REGISTRY 3 study.   
Results 
An exploratory factor analysis of a subsample of the data suggested a two-factor 
interpretation of the data comprising “temper” and “self-harm”. Eight possible models were 
tested for goodness-of-fit using confirmatory factor analysis. Two bifactor models, testing 
general and group factors in the structure of the scale, provided an equivocal “good” fit to the 
data. The first comprised a general irritability factor and two group factors (as originally 
proposed using Snaith’s Irritability Scale): outward irritability and inward irritability. The 
second comprised a general irritability factor and two group factors (as proposed by the 
exploratory factor analysis): temper and self-harm. The findings from both models suggested 
that the loadings of items were higher on the general factor. 
Conclusions 
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Bifactor models are proposed to best consider the structure of the Snaith Irritability Scale, 
with findings suggesting that an overall score should be used to measure irritability within 
Huntington’s disease populations. 
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INTRODUCTION          
Irritability is often reported in people with a variety of neurological conditions, including 
Parkinson’s disease1, Huntington’s disease (HD)2, Gilles de la Tourette Syndrome3, and 
traumatic brain injury
4
. Irritability is understood as a temporary mood state characterized by 
impatience, intolerance and poorly controlled anger
5
; it may result in verbal or behavioural 
outbursts, although the mood may be present without these observed manifestations, is 
subjectively unpleasant, and can be brief or prolonged
6
.  
Although irritability has not been the subject of significant empirical research across 
both clinical and normative samples, it warrants further study as it has important clinical 
implications. For example, among people with mental health difficulties, irritability is 
associated with poorer quality of life, higher suicidal ideation, and a greater history of suicide 
attempts
7
. Also, those who report irritable mood states are more likely to experience mood 
disorders, anxiety and impulse-control disorders, drug dependence, and a higher prevalence 
of fatigue
8
. Given these implications, it is important that clinicians and researchers accurately 




In terms of HD, an inherited movement disorder with cognitive decline and emotional 
difficulties, irritability is reported across all stages of the disease, including the pre-motor 
manifest period (ie. before clinical diagnosis of HD)
9-11
. The prevalence of irritability among 
HD gene expansion carriers varies across studies from 38% to 73%
2, 12
. Further, although 
irritability can correlate with other emotional difficulties in HD, such as depression and 
anxiety
13
, it demonstrates a distinct pattern of increasing severity among pre-motor 
symptomatic carriers as they become closer to motor onset, compared with these other 
difficulties
11, 14, 15
. Moreover, among people with HD, irritability is more closely related to 
aggression than other difficulties such as depression, apathy and anxiety
12, 16-19
. This 
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relationship with aggression, and thus the potential risk of causing harm to others, has 
highlighted irritability as a clinically and socially important construct to be studied among 
those with HD. Such consequences of irritable mood may also impact on provision of care, 
increasing the likelihood of HD patients having to move into a nursing home, rather than 
being managed in the community
20, 21
. Therefore, the interpersonal manifestations of 
heightened irritability may have a deleterious effect on caregivers
22
, resulting in protective 
factors such as social support and positive relationships becoming jeopardized. In addition to 
the risk of causing harm to others, there is the potential that facets of irritability in HD may 
also have associations with the risk of causing harm to self
23, 
though as yet this has received 
limited attention. For example, irritability has been found to be higher among HD gene 
expansion carriers with suicidal ideation than among those without
23
, a finding consistent 
with studies of those with mental health difficulties
5
. However, no predictive relationship 
between irritability and suicidality has been identified
23
 but this may be partly explained by 
the measure of irritability used, which has focused on outward conceptualisations of 
irritability
23
. Further understanding of the structural relationship of different aspects of 
irritability may help inform future studies examining relationships between suicide risk and 
irritability factors (i.e. both outward and inward expressions of irritable mood
5
). 
Within the literature available, irritability has most commonly been measured among 
HD gene expansion carriers using interviewer-rated assessments such as the Problem 
Behaviors Assessment (PBA)-HD
18




Although interviewer-based measures are useful in enabling assessment of mood 
among HD patients who may not be fully aware of their difficulties, brief self-report 
assessments offer benefits such as being quick and easy to administer, with no specific 
training required for administration. Self-assessment may also reveal information that some 
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individuals may find difficult to disclose in more formal interview settings. Currently, a self-
reported measure of irritability used within the field of HD research is the irritability subscale 
contained within the Irritability, Depression, Anxiety (IDA) Scale
5
, which has been used 
independently as an eight-item measure of irritability and is also referred to as the Snaith 
Irritability Scale (SIS)
25, 26
. Furthermore, the SIS is the only self-report measure of irritability 
currently used in large-scale longitudinal international HD studies, e.g. REGISTRY 
(http://www.euro-hd.net/html/registry) and ENROLL-HD (https://www.enroll-hd.org/).  
The US National Institute of Neurological Disorders and Stroke has recently 
highlighted the importance of validation studies for HD patient-reported instruments, 
especially when considering outcome measures for clinical trials
27
; therefore, it is necessary 
for psychometrically informed studies to be undertaken. In terms of the psychometric 
structure of the SIS, the recommended scoring of the scale comprises two factors: four 
irritability items within the scale measuring outwardly expressed irritability, and the other 
four examining inwardly expressed irritability
5
. However, psychometric validation studies of 
this instrument in clinical samples are limited, and no study has examined the psychometric 
properties of this scale within an HD population, including testing the assumption of the 
original scale as a two-factor model. 
In the field of psychometrics, higher-order solutions present alternative theoretical 
approaches for the examination of the factor structure of a scale. Rather than simply 
identifying the number of factors that emerge from an analysis of test items, higher-order 
factor analytic models introduce the concept of a general construct, and consider its relation 
to group factors formed from the items. Within this perspective, the central theoretical 
difference focuses on the presence of a general factor informing our understanding of the 
constructs being considered. Within higher-order factor models, typically two solutions are 
considered: second-order factor and bifactor models
28
. Second-order factor models present 
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the relationship between the factors and items portrayed using a hierarchical structure, with 
the variance of all items (at the bottom of the hierarchy) being explained by group factors 
(e.g. inward versus outward irritability), and the group factor variance being explained by a 
general latent factor (e.g. general irritability). With a bifactor model, the explained variance 
between the items is simultaneously considered between both the general and group factors. 
First, a single common construct (e.g. general irritability) is suggested to explain the shared 
variance between all of the items. Second, to recognize the multidimensionality of the 
construct, group factors are suggested (e.g. inward versus outward irritability), to also explain 
some of the shared variance between the items (see Figure 1 for an illustration).  
The inclusion of these models in understanding the factor structure of the SIS, if 
proved useful, may help inform treatment approaches. For example, in terms of the use of the 
SIS as an assessment tool, interventions could be informed by consideration of inward and 
outward irritability as separate constructs, with potential aetiological differences between the 
two. In contrast, within a higher-order solution, the treatment would additionally be informed 
by consideration of the aetiology of a general factor of irritability. There is good reason to 
propose an underlying general factor of irritability in HD due to the genetic heritability of the 
disease. A number of processes could underpin a general irritability factor (that encompasses 
both outward or inward manifestations of irritability) include the direct neuropathological 
changes
29
, cognitive appraisals regarding having HD
30 
and frustrations concerning the 
overwhelming impact that the disease has on one’s life31. Consequently, psychometric 
analysis using higher-order models may help inform how interventions may be targeted, in 
terms of understanding whether there are separate or related pathways that underpin the 
different facets of irritability among people with HD.    
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The aim of the current study was to conduct the first factor analysis study of the SIS 
within a large HD sample to explore the latent structure within this population and to evaluate 
the structure against different proposed models of the SIS.   
METHOD 
Sample and Measures. 
Data were obtained from the European HD Network (EHDN) following approval from the 
Scientific and Bioethics Advisory Committee. Our data request included all SIS assessments 
available from the REGISTRY 3 project. REGISTRY is a multinational, observational study 
examining the natural history of HD. As the initial dataset included longitudinal data 
involving repeated assessments of annual visits using the same participants (n=3234), we 
excluded all except the participants’ last visit (n=1474). We also excluded 210 respondents 
with incomplete irritability assessments, missing Total Functional Capacity (TFC) scores 
(measure of functional ability, ranging from 0-13, with lower scores reflecting reduced 
capacity to undertake daily living activities) or Total Motor Scores (TMS) (measure of 
different motor tasks, with higher scores indicating greater motor impairment) from the 
UHDRS, and those whose cytosine-adenine-guanine CAG repeat was ≤39 (to exclude those 
without the HD gene expansion). 
The final cross-sectional sample comprised 1264 participants with the HD gene 
expansion, who completed the SIS between 24
th
 June 2011 and 20
th
 February 2014, from the 
following European countries (n in brackets): Austria (12), Belgium (8), Czech Republic (3), 
Finland (4), France (303), Germany (287), Italy (38), Netherlands (97), Norway (17), Poland 
(228), Portugal (70), Spain (134), Sweden (5), Switzerland (7) and UK (51). Across all 
countries, participants gave written informed consent according to the full ethical approvals 
required for the REGISTRY study. Of these participants, 52.8% were female and the mean 
age of the sample at time of visit was 48.71 (sd=13.73, range 14-88 years).  
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To describe the clinical profile of the sample, we examined TFC scores, disease 
stage
32
 and the TMS scores from the UHDRS
24
. In terms of the profile of the sample, the 
TFC mean score was 8.54 (SD=3.94, range 0-13). Across the total sample, the breakdown of 
participants in each stage of HD was as follows (n in brackets): Premanifest (250), Stage I, 
with TFC scores of 11-13 (276), Stage II with TFC scores 7-10 (311), Stage III with scores 3-
6 (315), Stage IV with TFC scores of 1 or 2 (101) and Stage V with a TFC score of 0 (11). 
The mean TMS score was 33.55 (SD=24.50, range 0-108). 
 
RESULTS 
Exploratory Factor Analysis. 
The number of participants (632) to variables (8) ratio exceeded the recommended ratio for 
EFA of 10:1, with a minimum number of participants of 150
33
. Bartlett's test confirmed an 
EFA was appropriate for the sample (χ2[28]=15544.21, p<.001) and a Kaiser–Meyer–Olkin 
test (.83) indicated sufficient participants: item ratio of 79:1. Preliminary analyses of the 
scores on the items of the SIS demonstrated that seven items fell outside the criterion for a 
univariate normal distribution of between +/-1
34




Parallel analysis (where eigenvalues are compared to those calculated from purely 
random data) is the most appropriate and accurate method for determining the number of 
factors 
35, 36
. Within this analysis the third eigenvalue (3.60, 1.13 and .77) failed to exceed the 
third mean eigenvalue (1.17, 1.11, and 1.06) calculated from 1,000 generated datasets with 
501 cases and 8 variables. This suggested a two-factor solution (with the factors accounting 
for 44.94% and 14.22% of the variance respectively). Loadings were assessed against the 
thresholds of .32 (poor), .45 (fair), .55 (good), .63 (very good) and .71 (excellent)
37
 and are 
presented in Table 1. In terms of loadings above .45, the first factor comprises six items that 
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represent “temper”, encompassing inward and outward expressions of irritability such as 
“lose temper” and “feel like slamming doors” (items are abbreviated due to copyright). The 
second factor comprises two items referring to self-harm, “feel like harming myself” and 
“hurting myself occurs to me”.  
- Table 1 about here - 
A correlation between the two factors was r=.57, suggesting shared variance of 32.5%. The 
Cronbach's alpha coefficients
38
 for: the eight items was =.82; for the six items, =.80; and for the 
two items, =.76. These statistics exceed the criterion of >.70 as "Good"39, 40.  
Confirmatory Factor Analysis. 
To explore the structural validity of the SIS, a series of comparisons using CFA was 
performed using AMOS 22 software with the second sample data. A focus of CFA is to 
demonstrate the incremental value of proposed models
41
. Eight possible models were tested 
for goodness-of-fit. The first two were unidimensional models representing an underlying 
latent factor structure of general irritability (i) for the eight items of the SIS, and (ii) the six 
items that loaded on the first factor in the EFA. The third model tested was the proposed 
original two-factor structure for the SIS, inward and outward factors. The fourth model was 
the proposed two-factor structure resulting from our EFA of the SIS, temper and self-harm 
factors. The remaining models tested higher-order solutions for the data. The fifth and sixth 
models were second-order factor models in which general irritability formed the top level of a 
hierarchy in which inward versus outward (model 5) and temper and self-harm irritability 
(model 6) were group factors. The seventh and eighth models were higher-order bifactor 
models proposing a single common construct (general irritability) while recognising the 
multidimensionality of the construct; inward and outward (model 7) and temper and self-
harm irritability (model 8). 
  
Irritability in HD…  11 
 
 
 To assess the goodness-of-fit of the data, we used six statistics recommended by Hu 
and Bentler (1999)
42
 and Kline (2005)
43
: the chi-square (χ2), the relative chi-square 
(CMIN/DF), the comparative fit index (CFI), the non-normed fit index (NNFI), the root mean 
square error of approximation (RMSEA), and the standardized root mean square residual 
(SRMR). The following criteria was used to assess whether the model fit to the data was 
adequate (noting that the chi-square test was likely to be significant due to large sample 
size)
44
: (i) CMIN/DF must fall between 5 and 2 to be “acceptable”, and be less than 2 to be 
“good”, (ii) that the CFI and NNFI should exceed .90 to be “acceptable” and exceed .95 to be 
“good”, (iii) that the RMSEA should not exceed .08 to be “acceptable”, and be under .06 to 




- Table 2 about here - 
The goodness-of-fit statistics for the eight models are presented in Table 2. For the 
unidimensional, two-factor and second-order models, the large majority of the goodness-of-
fit statistics did not meet all the aforementioned criteria for acceptability, and therefore the 
models did not present an adequate explanation of the data. The bifactor models presented 
relative chi-square and RMSEA statistics that were acceptable and CFI, NNFI, and SRMR 
goodness-of-fit statistics all exceeding the “good” criteria. The findings for the bifactor 
models also demonstrate improved CFI statistics over the other models, as indicated by 
changes in CFI (ΔCFI) being >.01. 
- Figures 1 and 2 about here - 
The standardized loadings (with measurement error terms in parenthesis) for both 
suggested bifactor structures with general and group factors are presented in Figures 1 and 2. 
A number of statistics were used to examine the relative relationship between the general and 
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group factors. In terms of the original two factors of the SIS (inward and outward), the 
variance accounted for the general factor in this model was 64.2%, with inward and outward 
group factors explaining 13.7% and 22.1% respectively. In terms of salience of loading on 
the factors, the mean loadings were higher on the general factor (m=.59) than on the group 
factors (m=.41). The more traditional reliability estimates for the general and group factors 
were good: general factor =.83, omega total=.89; outward group factor =.78, omega 
total=.79; inward group factor =.77, omega total =.86. However, the omega hierarchical 
coefficient, which estimates the reliability with the effect of all the other factors removed, 
was low for the group factors (outward, omega hierarchical=.38; inward, omega 
hierarchical=.17) and was only acceptable for the general irritability factor (omega 
hierarchical=.71). 
The findings were similar in terms of the scoring derived from the EFA (i.e. temper 
and self-harm). The variance accounted for the general factor in this model was 67.3%, with 
inward and outward group factors explaining 12.1% and 20.5% respectively. In terms of 
salience of loading on the factors, the means loadings were higher on the general factor 
(m=.62) than on the group factors (m=.39). The more traditional reliability estimates for the 
general and group factors were good: general factor  = .83, omega total = .90; temper group 
factor =.80, omega total=.87; self-harm group factor =.84, omega total=.86. However, the 
omega hierarchical coefficient, was low for the group factors (temper, omega 
hierarchical=.15; self-harm, omega hierarchical=.54) and was only acceptable for the general 
irritability factor (omega hierarchical=.75). 
 
DISCUSSION 
Among a large European study of HD expansion carriers, we found that a bifactor 
interpretation is a structurally valid method of interpreting scores on the SIS, thus retaining 
the notion of an overall assessment of irritability, while recognising the multidimensionality 
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of the SIS. Two different considerations of the multidimensionality of the SIS were explored 
within the current study. The first was Snaith’s original conceptualization of outward and 
inward irritability
5
 and the second was suggested by findings from an EFA of “temper” and 
“self-harm” items. When these different conceptualizations of irritability were assessed 
further using CFA, we found that, regardless of whether the formulation comprised 
inward/outward dimensions or temper/self-harm dimensions, the statistical solution suggested 
that an overall score was the most stable. Therefore, based on the current findings, the 
primary recommendation is that all SIS items are used to produce an overall measure of 
irritability.  
These findings have relevance for the measurement and treatment of irritability in 
people with HD. A higher-order bifactor model suggests the accommodation of both general 
factor and group factors of irritability, with our findings suggesting that an emphasis should 
be made on the former. This implies a change in the understanding of what scores on the SIS 
represent among people with HD. It may not be enough simply to see the SIS as measuring 
two separate factors (inwards and outwards) or a unidimensional construct. Rather, while it is 
possible to recognize multidimensional aspects of the SIS, scores on the SIS are also 
informed by a general SIS factor. This suggests that, alongside group factors, a general factor 
of irritability may need to be considered. For example, this might be hypothesized as 
neuropathological changes that occur in HD having an underlying influence on SIS scores. 
Recent support for this hypothesis was provided by the TRACK-HD study that identified 
irritability to be associated with a distinct pattern of microstructural changes in the posterior 




The authors suggested that irritability may arise in situations 
when someone with HD may be stretched cognitively, and is consistent with another Track-
on study suggesting that left hemispheric deterioration appears to occur first in HD, with 
compensation by the right hemisphere as illustrated by fMRI
46
. Alternatively, generalized 
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irritability may be underpinned by other changes endemic to the experience of chronic illness, 
such as cognitions which are activated in a range of contexts and might lead to different 
behavioural/emotional outcomes depending on a range of individual or situational factors 
inherent to that specific context. 
These findings and suggestions have considerable significance, given that the study of 
irritability in HD, and other neurological disorders, is still in its infancy. The identification of 
inward and outward dimensions or temper and self-harm aspects of irritability, within a 
general factor of irritability, may be important in further considerations of irritability using 
the SIS. For example, researchers may wish to examine how the different formulations of 
irritability are associated with clinical risk, especially in the context of other factors in HD 
that may contribute to complex clinical presentations (such as executive functioning 
difficulties of heightened impulsivity, poor risk assessment, and reduced problem-solving 
strategies
47, 48)
. The clinical risks that could be associated with such conceptualisations of 
irritability may include physical aggression, risk of harming self, or heightening risk of being 
harmed by other people (e.g. through losing one’s temper easily with other people). Future 
research might wish to look at whether the aspects of irritability, as measured by the different 
formulations of the SIS, has any predictive utility regarding such risk behaviours among 
people with HD. Further consideration might be given to the various aspects of HD that 
potentially contribute to the general factor of irritability across the different stages of the 
disease. These range from biological contributions such as white matter changes
29
, to 
neuropsychological aspects such as cognitive overload
29
, to cognitive appraisals around 
having HD
30
, to frustrations over reduced functional, motor and cognitive abilities, and 
changes in personal relationships
31
.  
Despite these new findings, we also identify a number of potential limitations. The current 
REGISTRY sample may not be representative of the HD population as a whole. For instance, 
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participants within this study who were in the more advanced stages of the disease may have been 
less likely to have engaged in the research. Also, the data was collected from a Europe-wide sample 
involving translated versions of instruments. Therefore, in studying the data as a whole, we did not 
consider how expressions of irritability are construed differently cross-culturally, which suggests 
caution in applying the general findings to any single European sample.  
In summary, this paper outlines the first factor analysis study of scores obtained from the SIS 
across a large European sample of an HD population. The study provides evidence for two bifactor 
models and suggests a change is needed in how we should conceptually consider irritability in terms 
of both general and group factors. Mindful that irritability may stem from a general factor, we 
recommend that the SIS is best used as a general measure of irritability among HD gene expansion 
carriers. 
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Table 1.  Exploratory Factor Analysis (Principal Axis Factoring Extraction with Promax Rotation) of the Eight Irritability Items  
 
 Factor  
 1 2 
1. “lose temper” .82 -.10 
2. ”patient with people” (R) .57 -.06 
3. “angry with myself”  .49 .22 
4. “harming myself” .03 .73 
5. “hurting myself” -.08 .86 
6.  “lose control and hurt someone” .59 .01 
7. “feel like slamming doors or banging about” .69 -.01 
8. “annoyed with myself” .50 .24 
Key: (R) = reversed 
 
Table 2. Confirmatory Factor Analysis Fit Statistics for the Different Models Proposed for the SIS. 
 χ2 df P =< CMIN/DF CFI NNFI RMSEA SRMR 
Unidimensional (8 items) 475.31 20 .000 23.77 .753 .654 .190 .088 
Unidimensional (6 items) 150.62 9 .000 16.74 .875 .791 .158 .067 
Two factors (Inward / Outward) 265.31 19 .000 13.96 .866 .803 .129 .143 
Two factors (Temper / Self-harm) 265.31 19 .000 13.96 .866 .803 .129 .143 
Second-order (Inward / Outward) 265.31 19 .000 13.96 .866 .803 .143 .086 
Second-order (Temper / Self-harm) 181.81 19 .000 9.57 .912 .870 .117 .060 
Bifactor (Inward / Outward) 41.34 12 .000 3.45 .983 .963 .062 .025 
Bifactor (Temper / Self-harm) 41.34 12 .000 3.45 .984 .963 .062 .025 
 
 
